LY2780301
Product Specifications
CAS Number
1226801-23-5
Target
Akt, Others
Related Pathways
Others, Cytoskeletal Signaling, PI3K/Akt/mTOR signaling
Bioactivity
LY2780301 is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor LY2780301 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway, thereby leading to inhibition of cell proliferation and the induction of apoptosis in tumor cells. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents.
Smiles
C(CN(C)C)N1C(=NC(=C1)C2=CC(C(F)(F)F)=C(F)C=C2)C3CCN(CC3)C4=C5C(NC(=O)C5)=NC=N4
Molecular Formula
C25H27F4N7O
Molecular Weight
517.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SELL-233H 50 µg
Recombinant Human SELL Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details K1971007 1.0 µg DNA
RPL34P8 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details CABT-L2941-01 100 µl, 500 µl
Mouse Anti-Human CD43 monoclonal antibody, clone JID154
Sign In for Pricing
View Details